196 related articles for article (PubMed ID: 23921280)
1. Association of gamma-glutamyltransferase with severity of disease at diagnosis and prognosis of ovarian cancer.
Grimm C; Hofstetter G; Aust S; Mutz-Dehbalaie I; Bruch M; Heinze G; Rahhal-Schupp J; Reinthaller A; Concin N; Polterauer S
Br J Cancer; 2013 Aug; 109(3):610-4. PubMed ID: 23921280
[TBL] [Abstract][Full Text] [Related]
2. Gamma-glutamyltransferase as a preoperative differential diagnostic marker in patients with adnexal mass.
Reiser E; Aust S; Seebacher V; Reinthaller A; von Mersi H; Schwameis R; Polterauer S; Grimm C; Helmy-Bader S
Eur J Obstet Gynecol Reprod Biol; 2019 Aug; 239():16-20. PubMed ID: 31158789
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
Yang F; Zhang S; Yang H; Luo K; Wen J; Hu Y; Hu R; Huang Q; Chen J; Fu J
Dis Esophagus; 2015 Jul; 28(5):496-504. PubMed ID: 24766310
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
Wen YF; Yang XZ; Zeng LS; Peng HH; Huang WJ; Cai LM; Zhou TC; Lin XD
PLoS One; 2017; 12(2):e0172345. PubMed ID: 28241022
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial.
Seebacher V; Polterauer S; Grimm C; Rahhal J; Hofstetter G; Bauer EM; Husslein H; Leipold H; Marth C; Reinthaller A; Concin N
Br J Cancer; 2012 Apr; 106(9):1551-5. PubMed ID: 22315051
[TBL] [Abstract][Full Text] [Related]
6. Relevance of gamma-glutamyltransferase--a marker for apoptotic balance--in predicting tumor stage and prognosis in cervical cancer.
Polterauer S; Hofstetter G; Grimm C; Rahhal J; Mailath-Pokorny M; Kohl M; Concin N; Tempfer C; Marth C; Reinthaller A
Gynecol Oncol; 2011 Sep; 122(3):590-4. PubMed ID: 21664662
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma.
Dalpiaz O; Pichler M; Mrsic E; Reitz D; Krieger D; Venturino L; Bezan A; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC
J Clin Pathol; 2015 Jul; 68(7):547-51. PubMed ID: 25862811
[TBL] [Abstract][Full Text] [Related]
8. Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.
Hofbauer SL; Stangl KI; de Martino M; Lucca I; Haitel A; Shariat SF; Klatte T
Br J Cancer; 2014 Oct; 111(8):1526-31. PubMed ID: 25117808
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of pretherapeutic gamma-glutamyltransferase in patients with primary metastatic breast cancer.
Staudigl C; Concin N; Grimm C; Pfeiler G; Nehoda R; Singer CF; Polterauer S
PLoS One; 2015; 10(4):e0125317. PubMed ID: 25915044
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of serum γ-glutamyltransferase in patients with advanced urothelial carcinoma.
Takemura K; Fukushima H; Ito M; Kataoka M; Nakanishi Y; Sakamoto K; Suzuki H; Tobisu KI; Koga F
Urol Oncol; 2019 Feb; 37(2):108-115. PubMed ID: 30478012
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer.
Lv Q; Sun H; Cao C; Gao B; Qi Y
Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177
[TBL] [Abstract][Full Text] [Related]
14. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Serum Uric Acid and Gamma-Glutamyltransferase in Patients with Advanced Gastric Cancer.
Yang S; He X; Liu Y; Ding X; Jiang H; Tan Y; Lu H
Dis Markers; 2019; 2019():1415421. PubMed ID: 31885729
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Popa I; Bachvarov D
Int J Oncol; 2017 Dec; 51(6):1887-1897. PubMed ID: 29039611
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
Huo J; Hu J; Liu G; Cui Y; Ju Y
Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
[TBL] [Abstract][Full Text] [Related]
19. Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.
Fu SJ; Zhao Q; Ji F; Chen MG; Wu LW; Ren QQ; Guo ZY; He XS
Sci Rep; 2016 Jul; 6():28835. PubMed ID: 27381639
[TBL] [Abstract][Full Text] [Related]
20. Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma.
Schwameis R; Grimm C; Brodowicz T; Petru E; Hefler-Frischmuth K; Staudigl C; Reinthaller A; Heinze G; Polterauer S; Polterauer M
Sci Rep; 2016 Sep; 6():33757. PubMed ID: 27646551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
